Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
+30.9M
-
Total reported value, excl. options
-
$1.59B
-
Value change
-
+$450M
-
Put/Call ratio
-
0.8
-
Number of buys
-
92
-
Number of sells
-
-57
-
Price
-
$14.15
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q2 2015
178 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q2 2015.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 309M outstanding shares and own 36.34% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (14.4M shares), FMR LLC (13.1M shares), Redmile Group, LLC (6.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.82M shares), MILLENNIUM MANAGEMENT LLC (5.02M shares), Sectoral Asset Management Inc (5M shares), venBio Select Advisor LLC (4.59M shares), Citadel Advisors LLC (3.97M shares), BlackRock Fund Advisors (3.55M shares), and JENNISON ASSOCIATES LLC (3.37M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.